Cymbalta News
Most Popular Cymbalta Story
Lilly CEO sees sunny future for R&D shop amid criticisms
John Lechleiter hasn't followed his peers into the mega-merger fray, believing that Eli Lilly ($LLY) can survive the loss of patents on key drugs with its internal R&D programs and via Read more...
Latest Headlines
- November 22, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
